Umbilical Cord Blood Mononuclear Cells for Hypoxic Neurologic Injury in Infants With Congenital Diaphragmatic Hernia (CDH)



Status:Recruiting
Conditions:Gastrointestinal, Gastrointestinal
Therapuetic Areas:Gastroenterology
Healthy:No
Age Range:Any
Updated:10/12/2018
Start Date:August 1, 2018
End Date:November 1, 2027
Contact:Matthew T Harting, MD, MS
Email:matthew.t.harting@uth.tmc.edu
Phone:713-500-7300

Use our guide to learn which trials are right for you!

The purpose of this study is to investigate the use of autologous umbilical cord blood (UCB)
mononuclear cells to mitigate hypoxic neurologic injury among infants with high-risk
congenital diaphragmatic hernia (CDH).


Inclusion Criteria:

- Diagnosis of CDH between 20 and 36 weeks estimated gestational age (EGA)

- Only one of the following fetal criteria and one of the following postnatal criteria
must be met for enrollment. Fetal criteria: an ultrasound (US)-obtained observed to
expected lung to head ratio (o/e LHR) less than or equal to 35% or 2) a fetal magnetic
resonance imaging (fMRI)- obtained observed to expected total fetal lung volume (o/e
TFLV) less than or equal to 35%. Postnatal criteria: 1) Cord blood gas (CBG) with
potenital hydrogen (pH) <7.0, 2) Arterial blood gas (ABG) with pH <7.2 on 2 gasses
within the first 24 hours, 3) Preductal oxygen saturation (O2 sat) <90% x 2 total
hours (not necessarily consecutive) within the first 24 hours, or 4) Oxygenation Index
(OI) >20 x 2 total hours (not necessarily consecutive) within the first 24 hours.

Exclusion Criteria:

- Genetic/chromosomal abnormality: Trisomy 21, Trisomy 18, Trisomy 13 or other,
significant genetic abnormality. Microdeletions or other mild genetic abnormalities
are not considered exclusionary.

- Severe/major cardiac anomaly: coarctation of the aorta, combined atrial and
ventricular septal defects, hypoplastic left heart syndrome, tetralogy of fallot,
double outlet right ventricle, atrioventricular canal defects, or other
hemodynamically significant defects.

- Moderate/severe neurologic / intracranial abnormality: Grade III or IV
intraparenchymal hemorrhage, space occupying mass or lesion, or clinically significant
traumatic lesion such as a subdural or epidural hemorrhage.

- Prematurity <30 weeks estimated gestational age (EGA): Birth at 29 6/7 weeks or before

- Participation in an alternative prenatal intervention study: Fetoscopic Endotracheal
Occlusion (FETO)

- Unwillingness / inability to return for follow-up evaluation and assessment
We found this trial at
1
site
7000 Fannin St
Houston, Texas 77030
(713) 500-4472
Phone: 855-566-6273
University of Texas Health Science Center at Houston The University of Texas Health Science Center...
?
mi
from
Houston, TX
Click here to add this to my saved trials